| Aktsiad | 664,09 mld. | - | KoAct | 0 | Tervishoid | | 3.8.2023 | 22 564,21 | 9,78 | 37,04 |
| Aktsiad | 328,868 mld. | - | Tiger ETF | 0,40 | Tervishoid | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 6.10.2020 | 8634,27 | 5,68 | 62,93 |
| Aktsiad | 302,524 mld. | - | KODEX | 0,45 | Tervishoid | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 12 826,46 | 6,80 | 37,93 |
| Aktsiad | 219,546 mld. | - | Tiger ETF | 0,40 | Tervishoid | KRX Healthcare - KRW | 15.7.2011 | 50 531,24 | 5,37 | 46,27 |
| Aktsiad | 104,549 mld. | - | Tiger ETF | 0,30 | Tervishoid | NASDAQ Biotechnology Index | 26.8.2014 | 31 059,67 | 5,37 | 23,71 |
| Aktsiad | 103,384 mld. | - | KODEX | 0,09 | Tervishoid | KRX Healthcare - KRW | 28.3.2017 | 22 878,61 | 5,37 | 46,25 |
| Aktsiad | 99,758 mld. | - | Tiger ETF | 0,40 | Tervishoid | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 14.12.2016 | 19 333,26 | 11,87 | 59,10 |
| Aktsiad | 66,176 mld. | - | KODEX | 0,25 | Tervishoid | S&P Health Care Select Sector | 21.3.2023 | 13 706,88 | 5,12 | 23,06 |
| Aktsiad | 65,525 mld. | - | Tiger ETF | 0,49 | Tervishoid | Solactive China Biotech Index | 3.12.2020 | 8505,85 | 4,34 | 39,11 |
| Aktsiad | 55,733 mld. | - | KB RISE | 0 | Tervishoid | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 24.12.2024 | 15 804,25 | 9,56 | 68,04 |
| Aktsiad | 55,178 mld. | - | Tiger ETF | 0,45 | Tervishoid | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 10 718,75 | 10,72 | 21,80 |
| Aktsiad | 51,455 mld. | - | KODEX | 0,45 | Tervishoid | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 11 568,32 | 6,18 | 16,57 |
| Aktsiad | 41,506 mld. | 11,96 mln. | SPDR | 0,08 | Tervishoid | S&P Health Care Select Sector | 16.12.1998 | 157,70 | 5,11 | 22,91 |
| Aktsiad | 37,931 mld. | - | Tiger ETF | 0,40 | Tervishoid | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 23 037,90 | 3,42 | 40,82 |
| Aktsiad | 31,647 mld. | - | Tiger ETF | 0 | Tervishoid | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 29.6.2016 | 26 144,85 | 0 | 0 |
| Aktsiad | 27,833 mld. | - | Hwabao | 0,60 | Tervishoid | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,36 | 3,06 | 30,88 |
| Aktsiad | 20,702 mld. | - | KODEX | 0,25 | Tervishoid | S&P Biotechnology Select Industry | 31.10.2013 | 39 051,02 | 0 | 0 |
| Aktsiad | 18,06 mld. | - | E Fund | 0 | Tervishoid | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,38 | 3,37 | 26,68 |
| Aktsiad | 17,894 mld. | - | NH-Amundi | 0 | Tervishoid | | 26.11.2024 | 15 691,63 | 6,05 | 41,72 |
| Aktsiad | 17,167 mld. | 269 668,6 | Vanguard | 0,09 | Tervishoid | MSCI US IMI 25/50 Health Care | 26.1.2004 | 291,31 | 4,95 | 23,18 |
| Aktsiad | 15,958 mld. | - | KoAct | 0,50 | Tervishoid | | 11.11.2025 | 10 347,42 | 5,77 | 0 |
| Aktsiad | 12,903 mld. | - | KB RISE | 0 | Tervishoid | FnGuide HealthCare Index - KRW - Benchmark TR Net | 23.9.2016 | 17 819,46 | 5,38 | 42,23 |
| Aktsiad | 9,39 mld. | - | ACE | 0,45 | Tervishoid | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 19.11.2024 | 13 020,72 | 4,01 | 26,25 |
| Aktsiad | 9,202 mld. | - | ACE | 0,30 | Tervishoid | Solactive Global Big Pharma Index - Benchmark Price Return | 19.11.2024 | 12 952,99 | 7,82 | 23,23 |
| Aktsiad | 8,846 mld. | - | Kiwoom | 0,49 | Tervishoid | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 13 109,98 | 0 | 0 |
| Aktsiad | 8,302 mld. | 1,726 mln. | iShares | 0,44 | Tervishoid | NYSE Biotechnology (TR) | 5.2.2001 | 174,93 | 5,58 | 24,85 |
| Aktsiad | 7,514 mld. | 9,098 mln. | SPDR | 0,35 | Tervishoid | S&P Biotechnology Select Industry | 31.1.2006 | 125,54 | 4,95 | 0 |
| Aktsiad | 7,491 mld. | - | Tiger ETF | 0,50 | Tervishoid | FnGuide Medical Device Index - KRX - Benchmark TR Net | 7.11.2018 | 20 202,62 | 3,20 | 22,58 |
| Aktsiad | 7,32 mld. | - | KoAct | 0,50 | Tervishoid | | 3.9.2024 | 12 371,11 | 4,50 | 18,69 |
| Aktsiad | 6,69 mld. | - | Maxwealth | 0,60 | Tervishoid | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,51 | 2,65 | 31,19 |
| Aktsiad | 6,573 mld. | - | ChinaAMC | 0,65 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,81 | 3,00 | 21,32 |
| Aktsiad | 6,438 mld. | - | Bosera | 0,65 | Tervishoid | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,62 | 2,75 | 12,80 |
| Aktsiad | 5,861 mld. | - | Kiwoom | 0,49 | Tervishoid | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 11 588,74 | 4,74 | 18,54 |
| Aktsiad | 5,803 mld. | - | NEXT FUNDS | 0,32 | Tervishoid | | 21.3.2008 | 31 708,55 | 1,93 | 25,33 |
| Aktsiad | 5,441 mld. | - | Nippon | 0,19 | Tervishoid | Nifty Pharma Index - INR - Benchmark TR Gross | 2.7.2021 | 17,49 | 4,59 | 31,47 |
| Aktsiad | 5,378 mld. | - | KB RISE | 0,35 | Tervishoid | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 27.2.2024 | 10 150,30 | 8,99 | 20,36 |
| Aktsiad | 4,915 mld. | - | Tiger ETF | 0,40 | Tervishoid | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12 065,00 | 0 | 0 |
| Aktsiad | 4,778 mld. | - | ICBC | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 26.3.2025 | 1,25 | 0 | 0 |
| Aktsiad | 4,696 mld. | - | ChinaAMC | 0,75 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,35 | 3,56 | 28,98 |
| Aktsiad | 4,696 mld. | - | ChinaAMC | 0,75 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,35 | 3,56 | 28,98 |
| Aktsiad | 4,608 mld. | - | Invesco | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 16.10.2024 | 1,63 | 3,45 | 24,61 |
| Aktsiad | 4,473 mld. | 279 676,9 | iShares | 0,40 | Tervishoid | S&P Global 1200 / Health Care -SEC | 13.11.2001 | 100,34 | 4,70 | 23,01 |
| Aktsiad | 4,382 mld. | - | E Fund | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 18.3.2025 | 1,40 | 0 | 0 |
| Aktsiad | 3,764 mld. | - | Guotai | 0,60 | Tervishoid | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 1,01 | 0 | 0 |
| Aktsiad | 3,598 mld. | 1,645 mln. | iShares | 0,38 | Tervishoid | DJ US Select / Medical Equipment | 1.5.2006 | 58,39 | 4,18 | 26,55 |
| Aktsiad | 3,543 mld. | - | Xtrackers | 0,25 | Tervishoid | MSCI World Index / Health Care -SEC | 22.11.2010 | 59,12 | 4,78 | 22,84 |
| Aktsiad | 3,296 mld. | 703 053,1 | iShares | 0,38 | Tervishoid | Russell 1000 Health Care RIC 22.5/45 Capped Index | 12.6.2000 | 65,86 | 5,20 | 23,41 |
| Aktsiad | 3,203 mld. | - | Fullgoal | 0,60 | Tervishoid | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 1,39 | 0 | 0 |
| Aktsiad | 2,899 mld. | 183 916,4 | Fidelity | 0,08 | Tervishoid | MSCI US IMI 25/50 Health Care | 21.10.2013 | 75,19 | 5,00 | 23,10 |
| Aktsiad | 2,735 mld. | - | NH-Amundi | 0,45 | Tervishoid | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 9115,65 | 3,43 | 26,31 |
| Aktsiad | 2,729 mld. | - | iShares | 0,15 | Tervishoid | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 20.11.2015 | 12,63 | 5,15 | 23,07 |
| Aktsiad | 2,438 mld. | - | Hwabao | 0 | Tervishoid | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | - | 4,76 mld. | 0 | 0 |
| Aktsiad | 2,364 mld. | 123 159 | First Trust | 0,54 | Tervishoid | NYSE Arca Biotechnology Index | 19.6.2006 | 212,78 | 3,63 | 25,32 |
| Aktsiad | 2,3 mld. | - | Guotai | 0,60 | Tervishoid | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,45 | 3,06 | 30,91 |
| Aktsiad | 1,865 mld. | - | Ping An | 0,60 | Tervishoid | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,36 | 4,10 | 25,08 |
| Aktsiad | 1,681 mld. | - | E Fund | 0,20 | Tervishoid | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 1,11 | 2,50 | 20,25 |
| Aktsiad | 1,61 mld. | - | Harvest ETFs | 1,06 | Tervishoid | | 19.11.2014 | 7,51 | 4,93 | 21,81 |
| Aktsiad | 1,558 mld. | - | Guotai | 0,60 | Tervishoid | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 1.8.2025 | 0,88 | 0 | 0 |
| Aktsiad | 1,512 mld. | - | iShares | 0,18 | Tervishoid | MSCI Europe Health Care 20/35 Capped Index - EUR | 17.11.2020 | 7,40 | 4,24 | 21,39 |
| Aktsiad | 1,49 mld. | - | Amundi | 0,50 | Tervishoid | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 9937,75 | 2,82 | 14,76 |
| Aktsiad | 1,47 mld. | - | Cathay | 1,05 | Tervishoid | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 22.11.2021 | 7,93 | 3,36 | 18,14 |
| Aktsiad | 1,396 mld. | - | iShares | 0,46 | Tervishoid | S&P Global 1200 Healthcare Sector Index - AUD | 13.11.2001 | 138,63 | 0 | 0 |
| Aktsiad | 1,384 mld. | - | E Fund | 0,20 | Tervishoid | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,50 | 2,78 | 29,20 |
| Aktsiad | 1,363 mld. | - | E Fund | 0,20 | Tervishoid | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,42 | 4,33 | 29,55 |
| Aktsiad | 1,198 mld. | - | E Fund | 0,20 | Tervishoid | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,66 | 3,12 | 28,62 |
| Aktsiad | 1,164 mld. | 424 786,2 | VanEck | 0,36 | Tervishoid | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 110,49 | 5,21 | 20,15 |
| Aktsiad | 1,154 mld. | - | Xtrackers | 0,12 | Tervishoid | MSCI USA / Health Care -SEC | 12.9.2017 | 62,55 | 5,31 | 23,12 |
| Aktsiad | 1,154 mld. | - | Xtrackers | 0,12 | Tervishoid | MSCI USA / Health Care -SEC | 12.9.2017 | 62,55 | 5,31 | 23,12 |
| Aktsiad | 1,055 mld. | - | Harvest | 0,60 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 30.7.2025 | 0,88 | 0 | 0 |
| Aktsiad | 1,007 mld. | 107 236 | iShares | 0,38 | Tervishoid | DJ US Select / Pharmaceutical | 1.5.2006 | 90,39 | 4,78 | 24,04 |
| Aktsiad | 969,166 mln. | - | Global X | 0,59 | Tervishoid | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1706,15 | 2,09 | 21,22 |
| Aktsiad | 939,835 mln. | - | Amundi | 0,30 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 156,01 | 3,16 | 19,03 |
| Aktsiad | 939,835 mln. | - | Amundi | 0,30 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 156,01 | 3,16 | 19,03 |
| Aktsiad | 918,264 mln. | 29 986,87 | First Trust | 0,62 | Tervishoid | StrataQuant Health Care Index | 8.5.2007 | 115,52 | 2,84 | 16,99 |
| Aktsiad | 906,548 mln. | - | Wanjia | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 13.9.2024 | 1,57 | 3,45 | 24,61 |
| Aktsiad | 894,769 mln. | - | iShares | 0,35 | Tervishoid | NASDAQ Biotechnology Index | 19.10.2017 | 8,70 | 0 | 0 |
| Aktsiad | 886,244 mln. | - | CSOP | 1,50 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 21.7.2021 | 3,66 | 3,52 | 28,95 |
| Aktsiad | 773,778 mln. | - | Amundi | 0,30 | Tervishoid | MSCI World Index / Health Care -SEC | 19.8.2010 | 482,17 | 7,68 | 29,88 |
| Aktsiad | 762,288 mln. | 93 317,16 | Invesco | 0,40 | Tervishoid | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 32,72 | 3,30 | 21,29 |
| Aktsiad | 736,468 mln. | - | iShares | 0,46 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 25.4.2001 | 118,06 | 4,16 | 21,44 |
| Aktsiad | 726,421 mln. | 299 436,1 | iShares | 0,38 | Tervishoid | DJ US Select / Health Care Providers | 1.5.2006 | 45,09 | 2,26 | 16,51 |
| Aktsiad | 696,738 mln. | - | Cathay | 0,41 | Tervishoid | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 23.4.2019 | 30,59 | 0 | 0 |
| Aktsiad | 668,037 mln. | - | SPDR | 0,18 | Tervishoid | MSCI Europe Health Care Index - EUR | 5.12.2014 | 234,79 | 4,25 | 21,39 |
| Aktsiad | 650,658 mln. | - | SPDR | 0,30 | Tervishoid | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 29.4.2016 | 69,14 | 5,08 | 25,68 |
| Aktsiad | 644,081 mln. | - | Global X | 0,68 | Tervishoid | Solactive China Biotech Index | 25.7.2019 | 70,27 | 4,53 | 43,83 |
| Aktsiad | 644,081 mln. | - | Global X | 0,68 | Tervishoid | Solactive China Biotech Index | 25.7.2019 | 70,27 | 4,53 | 43,83 |
| Aktsiad | 585,477 mln. | - | ChinaAMC | 0,60 | Tervishoid | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 23.11.2023 | 0,89 | 2,65 | 31,16 |
| Aktsiad | 567,049 mln. | - | SPDR | 0,15 | Tervishoid | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 48,71 | 5,11 | 22,91 |
| Aktsiad | 564,93 mln. | - | iShares | 0,66 | Tervishoid | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 12.4.2011 | 72,07 | 0 | 0 |
| Aktsiad | 554,223 mln. | - | China Southern | 0,65 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 1,16 | 2,97 | 21,35 |
| Aktsiad | 540,234 mln. | - | Fullgoal | 0,60 | Tervishoid | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 0,94 | 0 | 0 |
| Aktsiad | 511,05 mln. | 608 183,1 | Direxion | 0,93 | Tervishoid | S&P Biotechnology Select Industry | 28.5.2015 | 166,89 | 0 | 0 |
| Aktsiad | 486,731 mln. | - | Guotai | 0,60 | Tervishoid | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,73 | 3,51 | 27,58 |
| Aktsiad | 433,554 mln. | - | Invesco | 0,40 | Tervishoid | NASDAQ / Biotechnology | 6.11.2014 | 60,39 | 5,34 | 23,31 |
| Aktsiad | 422,38 mln. | - | China Southern | 0,20 | Tervishoid | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 12.3.2021 | 0,66 | 3,12 | 28,62 |
| Aktsiad | 410,449 mln. | - | Invesco | 0,14 | Tervishoid | S&P Select Sector Capped 20% Health Care Index | 16.12.2009 | 763,45 | 5,10 | 22,93 |
| Aktsiad | 406,855 mln. | 46 155,16 | Invesco | 0,57 | Tervishoid | Dynamic Pharmaceutical Intellidex Index (AMEX) | 23.6.2005 | 110,47 | 3,10 | 19,80 |
| Aktsiad | 401,236 mln. | - | Maxwealth | 0,60 | Tervishoid | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 2.4.2025 | 1,48 | 0 | 0 |
| Aktsiad | 386,912 mln. | 6857,645 | VanEck | 0,35 | Tervishoid | MVIS US Listed Biotech 25 | 20.12.2011 | 199,23 | 5,01 | 24,93 |
| Aktsiad | 303,525 mln. | - | Capital | 1,01 | Tervishoid | NASDAQ Biotechnology Index | 9.1.2017 | 35,35 | 5,23 | 22,78 |